Home » Healthcare » ACTA is worse than SOPA.

ACTA is worse than SOPA.

The recently leaked U.S. IP chapter also includes provisions that appear to go beyond current U.S. Rules. This raises significant concerns for citizens’ credited process, privacy and independence of expression rights. SOPA could be history but that doesn’t mean Internet independence does not stay under assault. Tyrants by no means stop trying to enforce tyranny.. ACTA is worse than SOPA, some tips about what you need to know As a warrior for Internet freedom, you helped defeat the Stop On the web Piracy Act, or SOPA by supporting Web dark outs by sites like Wikipedia and by contacting your lawmaker to tone of voice your displeasure.

Schaafsma, M.D., Michael Gregor, M.D., Matthias Theobald, M.D., Urs Schanz, M.D., Johan Maertens, M.D., and Gert J. Ossenkoppele, M.D.1 It had been initially used in remission-induction therapy at a dose of 100 to 200 mg per square meter of body-surface area. From about 1975 to 1985, investigators began evaluating the usage of high-dose cytarabine therapy, given in a dose of 3000 mg per square meter twice daily for 6 days.2,3 In single-group studies, high response rates were noted among individuals with relapse and promising outcomes were reported for those with a new diagnosis of AML.2-4 Subsequently, a randomized study showed that four cycles of cytarabine at a dose of 3000 mg per square meter given twice daily on times 1, 3, and 5 and administered after complete remission appeared to be superior to cytarabine at a dose of 100 or 400 mg per square meter with respect to overall survival and relapse-free survival in patients young than 60 years.5 High-dose cytarabine is becoming acceptable postremission consolidation therapy in U.S.Schaafsma, M.D., Michael Gregor, M.D., Matthias Theobald, M.D., Urs Schanz, M.D., Johan Maertens, M.D., and Gert J. Ossenkoppele, M.D.1 It had been initially used in remission-induction therapy at a dose of 100 to 200 mg per square meter of body-surface area. From about 1975 to 1985, investigators began evaluating the usage of high-dose cytarabine therapy, given in a dose of 3000 mg per square meter twice daily for 6 days.2,3 In single-group studies, high response rates were noted among individuals with relapse and promising outcomes were reported for those with a new diagnosis of AML.2-4 Subsequently, a randomized study showed that four cycles of cytarabine at a dose of 3000 mg per square meter given twice daily on times 1, 3, and 5 and administered after complete remission appeared to be superior to cytarabine at a dose of 100 or 400 mg per square meter with respect to overall survival and relapse-free survival in patients young than 60 years.5 High-dose cytarabine is becoming acceptable postremission consolidation therapy in U.S.